Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vollenweider

Showing results (41-50 of 481) with videos related to

Pageof 49
Sort By:
BMC Public Health|January 14, 2018
Socio-demographic and lifestyle determinants of dietary patterns in French-speaking Switzerland, 2009-2012Pedro Marques-Vidal, Gérard Waeber, Peter Vollenweider, et al.
Public Health Nutrition|October 19, 2018
Association between dietary intake and inflammatory markers: results from the CoLaus studyEva Piccand, Peter Vollenweider, Idris Guessous, et al.
Journal of Hypertension|April 28, 2015
Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelinesPedro Marques-Vidal, Gérard Waeber, Bernard Waeber, et al.
Revue Medicale Suisse|January 20, 2021
Idris Guessous, Peter Vollenweider, Jean-Luc Reny, et al.
Diabetes Care|June 4, 2011
Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the Cohorte Lausannoise studyRémy Schmid, Peter Vollenweider, Gérard Waeber, et al.
Atherosclerosis|August 23, 2011
Association of statins with inflammatory cytokines: a population-based Colaus studyTanica Lyngdoh, Peter Vollenweider, Gérard Waeber, et al.
BMC Pharmacology & Toxicology|April 2, 2014
Antihypertensive drug treatment changes in the general population: the CoLaus studyVanessa Christe, Gérard Waeber, Peter Vollenweider, et al.
Cytokine|March 6, 2014
Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study)Julien Vaucher, Pedro Marques-Vidal, Gérard Waeber, et al.
International Journal of Cardiology|August 14, 2012
Who is at low risk for cardiovascular disease? An assessment of different definitionsAntoine Gabioud, Gérard Waeber, Peter Vollenweider, et al.
International Journal of Cardiology|December 14, 2020
Clinical factors associated with the intraventricular conduction disturbances in Swiss middle-aged adults: The CoLaus|PsyCoLaus studyMarylène Bay, Peter Vollenweider, Pedro Marques-Vidal, et al.
Pageof 49

Showing results (41-50 of 481) with videos related to

Sort By:
Pageof 49
BMC Public Health|January 14, 2018
Socio-demographic and lifestyle determinants of dietary patterns in French-speaking Switzerland, 2009-2012Pedro Marques-Vidal, Gérard Waeber, Peter Vollenweider, et al.
Public Health Nutrition|October 19, 2018
Association between dietary intake and inflammatory markers: results from the CoLaus studyEva Piccand, Peter Vollenweider, Idris Guessous, et al.
Journal of Hypertension|April 28, 2015
Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelinesPedro Marques-Vidal, Gérard Waeber, Bernard Waeber, et al.
Revue Medicale Suisse|January 20, 2021
Idris Guessous, Peter Vollenweider, Jean-Luc Reny, et al.
Diabetes Care|June 4, 2011
Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the Cohorte Lausannoise studyRémy Schmid, Peter Vollenweider, Gérard Waeber, et al.
Atherosclerosis|August 23, 2011
Association of statins with inflammatory cytokines: a population-based Colaus studyTanica Lyngdoh, Peter Vollenweider, Gérard Waeber, et al.
BMC Pharmacology & Toxicology|April 2, 2014
Antihypertensive drug treatment changes in the general population: the CoLaus studyVanessa Christe, Gérard Waeber, Peter Vollenweider, et al.
Cytokine|March 6, 2014
Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study)Julien Vaucher, Pedro Marques-Vidal, Gérard Waeber, et al.
International Journal of Cardiology|August 14, 2012
Who is at low risk for cardiovascular disease? An assessment of different definitionsAntoine Gabioud, Gérard Waeber, Peter Vollenweider, et al.
International Journal of Cardiology|December 14, 2020
Clinical factors associated with the intraventricular conduction disturbances in Swiss middle-aged adults: The CoLaus|PsyCoLaus studyMarylène Bay, Peter Vollenweider, Pedro Marques-Vidal, et al.
Pageof 49